CTRI/2024/07/071061尚未招募Unknown
Post-approval, observational study to assess clinical safety and effectiveness of Azelnidipine and Telmisartan in management of Diabetic HTN - TELAZ
Torrent Pharmaceuticals Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Male or Female patients 18 to 65 years.
- •2.Known cases of T2DM with HTN as Treatment naïve or uncontrolled receiving background ARB therapy for at least four weeks
- •3.Patients with systemic Blood pressure =140/90 mm/Hg.
排除标准
- •1.Patients with T1DM.
- •2.Patients with impaired hepatic function with liver enzymes 5X ULN
- •3.Current state as pregnant or breast-feeding
- •4.Patients not willing for follow –up during the course of the study @ 8W and 24W
研究者
相似试验
尚未招募
Unknown
To evaluate the efficacy and safety assessment of Nicorandil in ASCVD with AnginaCTRI/2024/01/061624Torrent Pharmaceutical Ltd
尚未招募
Unknown
Study on the Effectiveness and Safety of Once-Daily Brivaracetam for Drug-Resistant Focal Onset EpilepsyCTRI/2024/07/070210Torrent Pharmaceuticals Ltd
尚未招募
4 期
Study to check the result and safety of combination treatment of vildagliptin and dapagliflozin in type 2 diabetes mellitus patientCTRI/2022/08/044757Torrent Pharmaceuticals Ltd
尚未招募
不适用
Study to check the safety and benefits of medicine Bisoprolol in Heart disease patientsCTRI/2023/01/049287Torrent Pharmaceuticals Ltd
尚未招募
4 期
To assess safety and effectiveness of Sitagliptin, Glimepiride, and Metformin for diabetes patients in India.CTRI/2024/03/064004Torrent Pharmaceuticals Ltd